Global Alirocumab Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Alirocumab market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Alirocumab is a human monoclonal antibody. It works by helping the liver reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL) circulating in your blood.Alirocumab is used in adults with heart disease to lower the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.

This report is a detailed and comprehensive analysis for global Alirocumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Alirocumab market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031

Global Alirocumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031

Global Alirocumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031

Global Alirocumab market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Alirocumab

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Alirocumab market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AK Scientific, Carbosynth, TargetMol Chemicals, Beijing Aomi Jiade Pharmaceutical Technology, Hefei Hirisun Pharmatech, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology, Jiangxi Ruiweier Biotechnology, Kailide Biomedical Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Alirocumab market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Patent

Generic

Market segment by Application

Biochemical Reagents

Pharmaceutical Intermediates

Major players covered

AK Scientific

Carbosynth

TargetMol Chemicals

Beijing Aomi Jiade Pharmaceutical Technology

Hefei Hirisun Pharmatech

Hubei Widely Chemical Technology

Hubei Xingcheng Biotechnology

Hubei Zhongshan Medical Technology

Jiangxi Ruiweier Biotechnology

Kailide Biomedical Technology

Nantong Feiyu Biological Technology

Nantong Hi-Future Biotechnology

Shanghai Baishikai Chemical Technology

Shanghai Biochempartner

Shanghai Loulan Biotechnology

Shanghai Macklin Biochemical

Shanghai Minkai Biotechnology

Shanghai Ruihui Chemical Technology

Shanghai Saimai Biotechnology

Shanghai Yifei Biotechnology

Sichuan Weiqi Biotechnology

Taizhou KEDE Chemical

Taizhou Kerui Bio-Technology

Tianmen Hengchang Chemical

WeiShi Reagent

Wuhan Dingxintong Pharmaceutical

Wuhan Fortuna Chemical

Wuhan Sunrise Technology Development

Wuhan Weisman Bioengineering

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Alirocumab product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Alirocumab, with price, sales quantity, revenue, and global market share of Alirocumab from 2020 to 2025.

Chapter 3, the Alirocumab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Alirocumab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Alirocumab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Alirocumab.

Chapter 14 and 15, to describe Alirocumab sales channel, distributors, customers, research findings and conclusion.